報價延遲最少15分鐘:2025/06/04 15:23 EDT
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.05 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-1.00/-0.49
|
|
企業價值
229.98M
|
| 資產負債 |
|
每股賬面淨值
1.28
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
65.17M
|
|
每股收益
0.88
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘：2025/06/04 15:23 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing dataand generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil. |